Essilor launches first 3D virtual reality headset for demonstrating lens benefits

New tool, Nautilus, illustrates practitioner’s recommendations to the patient in virtual real life situations

16 Dec 2015 by Robina Moss

Essilor has launched a 3D virtual reality headset called Nautilus. Described by the company as “the new generation of lens demonstration tool,” Nautilus has been designed to be used in practice.

The device has been created to help the practitioner during the dispensing process and to enhance the patient journey.

Using Nautilus, patients are able to see and virtually test the lens solutions recommended by their practitioner by being totally immersed in a 3D real life virtual environment.

The Nautilus is a combination of a headset, which works with a smartphone, a tablet and an app.

The smartphone sits inside the headset and acts as a screen for the patient, with the practitioner using the tablet as a controller. The patient wearer experiences real-life situations, with 360° and interactive scenes.

By experiencing situations virtually, such as walking down stairs or looking around a picture gallery, patients can see what benefits their future lenses could bring them.

With the tablet, the practitioner selects what products they want the wearer to experience and, for example, with a progressive lens trial, the impact of distortion, the effects of dust or fog, and the benefits of polarised and photochromic lenses can be demonstrated.

The new tool can be adjusted to suit the patient’s pupillary distance and their prescription.

Essilor’s research and development laboratories have been using virtual simulation to test new lens concepts for the last 10 years.

Nautilus was debuted at the National Eyecare Group conference (22–23 November) in Leicestershire, where practitioners could try the device out for themselves.

For more information, practitioners should contact their Essilor lens account manager or visit the Essilor website.


Your comments

You must be logged in to join the discussion. Log in

Comments (0)